EXFO Extends 40G/100G OTN Multiplexing Test Capabilities on FTB/IQS 85100G Packet Blazer Test Modules

EXFO Inc. today announced the extension of the 40G/100G optical transport network (OTN) multiplexing test capabilities on its FTB/IQS 85100G Packet Blazer 40G/100G multiservice test modules.

These capabilities include a full spectrum of OTU4 (111.81 Gbit/s) single-stage multiplexing schemes, in addition to Gigabit Ethernet (GigE) and 10 Gigabit Ethernet (10 GigE) client mappings into 40G/100G optical-channel payload units (OPUs) as per ITU-T G.709 for breakthrough-level qualification of 40G/100G muxponders. These additional capabilities are available as software options for existing FTB/IQS-85100G Packet Blazer modules, thus maximizing customers' return on investment (ROI) without requiring any additional hardware.

In today's competitive market, service providers are striving to address bandwidth needs by upgrading their core and metro networks to 100G capacity. However, 10G services remain the biggest contributor to service providers' revenues. Accordingly, network element manufacturers (NEMs) are continuously enhancing their 40G/100G cross-connect offering to ensure that it is able to carry, switch and terminate 10G (and lower) rate services in line with proper bandwidth usage without compromising their quality.

EXFO's new 40G/100G multiplexing capability provides an in depth test suite for full simulation and analysis of GigE and 10 GigE real-life services, along with full access to control and monitoring of OTN overhead bytes, tandem-connection-monitoring (TCM) traces and forward error correction (FEC) algorithms. These functionalities ensure that all newly deployed 40G/100G muxponders are proven capable of handling the demanding services that will be placed on them in the future.

In addition to newly launched OTN testing capabilities, EXFO's FTB/IQS-85100G Packet Blazer modules now support 40GE/100GE service disruption time (SDT) measurement for validation of 40G/100G Ethernet network-failure recovery mechanisms, thereby ensuring the availability and reliability of high-speed services.

"Over the past few years, EXFO has been a leading provider of high-speed multiservice testing solutions, and the extension of our 40G/100G Ethernet and OTN test capabilities continues on that trend" said Claudio Mazzuca, Vice-President of EXFO's Transport and Service Assurance Division. "Our customers are under pressure to speed up their time-to-market, so we are now more determined than ever before to maintain our leadership position and align our development efforts in order to meet our customers' lab and field testing needs."

For more information about the FTB/IQS-85100G Packet Blazer 40G/100G multiservice test modules, please visit www.EXFO.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    EXFO Inc.. (2019, February 26). EXFO Extends 40G/100G OTN Multiplexing Test Capabilities on FTB/IQS 85100G Packet Blazer Test Modules. AZoOptics. Retrieved on November 21, 2024 from https://www.azooptics.com/News.aspx?newsID=18157.

  • MLA

    EXFO Inc.. "EXFO Extends 40G/100G OTN Multiplexing Test Capabilities on FTB/IQS 85100G Packet Blazer Test Modules". AZoOptics. 21 November 2024. <https://www.azooptics.com/News.aspx?newsID=18157>.

  • Chicago

    EXFO Inc.. "EXFO Extends 40G/100G OTN Multiplexing Test Capabilities on FTB/IQS 85100G Packet Blazer Test Modules". AZoOptics. https://www.azooptics.com/News.aspx?newsID=18157. (accessed November 21, 2024).

  • Harvard

    EXFO Inc.. 2019. EXFO Extends 40G/100G OTN Multiplexing Test Capabilities on FTB/IQS 85100G Packet Blazer Test Modules. AZoOptics, viewed 21 November 2024, https://www.azooptics.com/News.aspx?newsID=18157.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.